English
|
简体中文
|
繁體中文
|
한국어
|
日本語
Home
|
About us
|
Services
|
Partners
|
Events
|
Contact us
|
Login
Wednesday, May 14, 2025
9:00:58 PM HKT
Press Releases for Wednesday, June 5, 2024
GMG's THERMAL-XR(R) Energy Savings Coating Wins Industry Product Excellence Award
20:09 HKT/SGT
MHI and EGAT sign MoU to Introduce Hydrogen Large Gas Turbine Co-firing Technology in Thailand to Achieve Net Zero Goals
18:09 HKT/SGT
Mitsubishi Shipbuilding Receives Additional Order for 2 Units of LNG Fuel Gas Supply System (FGSS)
17:14 HKT/SGT
NEC announces external appointment of executive personnel
16:43 HKT/SGT
3rd Clean Power & New Energy 2024; Take a Deep Dive into the Latest Transition of Renewable Energies
15:31 HKT/SGT
Startup ecosystem in Southeast Asia and India show signs of maturity - Profitability and customer-centricity take centre stage: HubSpot Study
15:00 HKT/SGT
Pride for All: Thailand Celebrates and Empowers Equality and Gender Diversity for Pride Month 2024
14:00 HKT/SGT
Advancing Customer Experience Solutions at World CX Summit and Awards
13:40 HKT/SGT
Kucingko Inks Underwriting Agreement with Kenanga Investment Bank
13:00 HKT/SGT
Fintech360 and TradingView Enter into Partnership for Innovation and Efficiency
12:00 HKT/SGT
三菱造船、LNG燃料ガス供給システム(FGSS)2基を追加受注
11:47 HKT/SGT
JCB collaborates with Singapore's Mandai Wildlife Group to promote wildlife park visitorship
11:00 HKT/SGT
君聖泰醫藥將在2024年國際肝病大會發布MASH臨床2a期研究分析結果,進一步展現熊去氧膽小檁鹼(HTD1801)的療效與安全性
09:00 HKT/SGT
君圣泰医药将在2024年国际肝病大会发布MASH临床2a期研究分析结果,进一步展现熊去氧胆小檗碱(HTD1801)的疗效与安全性
09:00 HKT/SGT
HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress, Reinforcing and Further Characterizing the Efficacy and Safety of Berberine Ursodeoxcyholate (HTD1801)
09:00 HKT/SGT
Rover Announces Intent to Pursue Strategic Alternatives for Its Cabin Gold Project
07:00 HKT/SGT
ACN Search:
TrustCSI 3.0 Navigates the 'Belt and Road' and Empowers Global Enterprise's Digital Journey
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home
|
About us
|
Services
|
Partners
|
Events
|
Login
|
Contact us
|
Cookies Policy
|
Privacy Policy
|
Disclaimer
|
Terms of Use
|
RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575